# Harriet M. Kluger

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/harriet-m-kluger/

## Facts

| Field | Value |
| --- | --- |
| Citations | 32,354 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 80 |
| i10-index | 272 |
| Last Known Institution | Yale Cancer Center |
| OpenAlex ID | https://openalex.org/A5001175430 |
| ORCID iD | https://orcid.org/0000-0002-4932-9873 |
| Works | 841 |

## Researcher papers

- [Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis of consecutive cohorts of the C-144-01 study](https://scholariq.org/papers/efficacy-and-safety-of-lifileucel-a-one-time-autologous-tumor-infiltrating/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [Cutaneous Melanoma Detection and Management](https://scholariq.org/topics/cutaneous-melanoma-detection-and-management/)

## Researcher university

- [Yale Cancer Center](https://scholariq.org/institutions/yale-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.